BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2894653)

  • 1. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
    Anderson JL
    Postgrad Med; 1988 Feb; Spec No():104-12. PubMed ID: 2894653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockers.
    Waagstein F
    Herz; 1985 Jun; 10(3):143-8. PubMed ID: 2862098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)].
    Sigmund M; Reineke T
    Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-adrenergic blocking agents in congestive heart failure.
    Krukemyer JJ
    Clin Pharm; 1990 Nov; 9(11):853-63. PubMed ID: 1980240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
    Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenergic betablockers and heart failure].
    Lechat P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):611-5. PubMed ID: 7487311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical analysis of beta blockers in heart failure: certainty and incompleteness].
    Rapezzi C; Branzi A
    Ital Heart J Suppl; 2000 Aug; 1(8):1003-10. PubMed ID: 10993006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
    Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
    Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockade in adriamycin-induced cardiomyopathy.
    Noori A; Lindenfeld J; Wolfel E; Ferguson D; Bristow MR; Lowes BD
    J Card Fail; 2000 Jun; 6(2):115-9. PubMed ID: 10908085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.
    Zhan DY; Morimoto S; Du CK; Wang YY; Lu QW; Tanaka A; Ide T; Miwa Y; Takahashi-Yanaga F; Sasaguri T
    Cardiovasc Res; 2009 Oct; 84(1):64-71. PubMed ID: 19477965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.